Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Cancellieri

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLCFederico Cappuzzo, Vanesa Gregorc, Elisa Rossi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2025
Complete Response to Lorlatinib in Lung Adenocarcinoma With EML4-ALK Fusion Variant (E6;A18): Case Report and Literature ReviewAntonio Vitale, Elisa De Paolis, Jacopo Russo, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 26, 2026
Metastatic Granular Cell Tumor of the Vulva With CHEK2 Mutation: A Case Report and Molecular InsightsArianna Salvador, Qianqian Zhang, Angela Santoro, et al.
Frontiers in Oncology|December 14, 2023
Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapyFederica D'Antonio, Sabrina Rossi, Isabella Giovannoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)Federico Cappuzzo, Claudia Ligorio, Claudio Ligorio, et al.
Chest|April 30, 2023
High-Definition Videobronchoscopy for the Diagnosis of Airway Involvement in Sarcoidosis: The Enhance Sarcoidosis Multicenter StudyVanina Livi, Ilya Sivokozov, Jouke T Annema, et al.
Plos One|May 19, 2017
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinomaDario de Biase, Giovenzio Genestreti, Michela Visani, et al.
Journal of Thoracic Disease|August 14, 2025
Short-term results of salvage surgery after immune and target therapies in non-small cell lung cancerMarco Chiappetta, Carolina Sassorossi, Filippo Lococo, et al.
Frontiers in Oncology|July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case reportEttore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Frontiers in Oncology|May 3, 2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future OpportunitiesMiriam Grazia Ferrara, Alessio Stefani, Michele Simbolo, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLCFederico Cappuzzo, Vanesa Gregorc, Elisa Rossi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2025
Complete Response to Lorlatinib in Lung Adenocarcinoma With EML4-ALK Fusion Variant (E6;A18): Case Report and Literature ReviewAntonio Vitale, Elisa De Paolis, Jacopo Russo, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 26, 2026
Metastatic Granular Cell Tumor of the Vulva With CHEK2 Mutation: A Case Report and Molecular InsightsArianna Salvador, Qianqian Zhang, Angela Santoro, et al.
Frontiers in Oncology|December 14, 2023
Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapyFederica D'Antonio, Sabrina Rossi, Isabella Giovannoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)Federico Cappuzzo, Claudia Ligorio, Claudio Ligorio, et al.
Chest|April 30, 2023
High-Definition Videobronchoscopy for the Diagnosis of Airway Involvement in Sarcoidosis: The Enhance Sarcoidosis Multicenter StudyVanina Livi, Ilya Sivokozov, Jouke T Annema, et al.
Plos One|May 19, 2017
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinomaDario de Biase, Giovenzio Genestreti, Michela Visani, et al.
Journal of Thoracic Disease|August 14, 2025
Short-term results of salvage surgery after immune and target therapies in non-small cell lung cancerMarco Chiappetta, Carolina Sassorossi, Filippo Lococo, et al.
Frontiers in Oncology|July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case reportEttore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Frontiers in Oncology|May 3, 2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future OpportunitiesMiriam Grazia Ferrara, Alessio Stefani, Michele Simbolo, et al.
Pageof 10